Controlling the PI3K/AKT/mTOR signaling pathways has been demonstrated to decrease inflammation, modulate immune response, hinder oxidative stress, and relieve LPS-induced ALI. The gene discussed is AKT1; the disease is acute respiratory distress syndrome.